Four years after a single dose of SRP-9001 gene therapy, four children with Duchenne muscular dystrophy show sustained stabilization of motor function that would otherwise show expected decline.
From sports injuries to arthritis, movement analysis that used to take days can be done in 10 minutes potentially improving patient outcomes while uncovering mysteries of human mobility.